There are 2789 resources available
796P - Association between biomarkers and clinical outcomes of lenvatinib (L) + pembrolizumab (P) in advanced endometrial cancer (EC): Results from KEYNOTE-146/study 111
Presenter: Vicky Makker
Session: ePoster Display
798P - A phase II study of pembrolizumab (P) in combination with doxorubicin (D) in advanced endometrial cancer (AEC): TOPIC trial/VHIO10001
Presenter: Lorena Fariñas-Madrid
Session: ePoster Display
799P - Anlotinib plus sintilimab in patients with recurrent advanced endometrial cancer: A prospective open-label, single-arm, phase II clinical trial
Presenter: Wei Wei
Session: ePoster Display
800P - Tailoring adjuvant treatments in high-risk early stage endometrial cancer: Clinical outcomes of sequential chemoradiation in a real-word scenario
Presenter: Marco de Scordilli
Session: ePoster Display
801P - Response to first-line platinum chemotherapy in microsatellite instability high (MSI-H) metastatic endometrial carcinoma
Presenter: Emeline Colomba
Session: ePoster Display
802P - A machine learning-based framework for efficacy and safety analysis of PD-1PD-L1 inhibitor application in gynaecological cancer on incomplete post-marketing surveillance dataset
Presenter: xiaomei Liu
Session: ePoster Display
803P - An histopathological algorithm to help the search for POLE mutated endometrial cancers
Presenter: Leslie Tessier
Session: ePoster Display
754P - Neoadjuvant chemotherapy followed by interval debulking surgery for advanced epithelial ovarian cancer in Japan - GOTIC-019: A multi-institutional retrospective cohort study
Presenter: Shoji Nagao
Session: ePoster Display
755P - A machine learning approach applied to gynaecological ultrasound to predict progression-free survival in ovarian cancer patients
Presenter: Francesca Arezzo
Session: ePoster Display